drugset / Trial / NCT05683951

Clinical Trial to Evaluate the Efficacy and Safety of DWKH

NCT05683951 ↗

Phase 3 Completed 186 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized, Double-blind, Parellel, Multicenter, Active-controlled

Timeline

Start
2021-11-26
Primary completion
2022-12-09
Completion
2022-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject DWKH Unknown — —
Comparator DWKH-R Unknown — —